Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
DMH-Negma, a subsidiary of the pharmaceutical Indian group Wockhardt, announced its intention to lay off its 130 sales representatives. The company had been placed into compulsory liquidation on 25 March 2011.
DMH-Negma is a fully integrated pharmaceutical Group mastering the various stages of the life cycle of its products from R&D, API manufacturing, to manufacturing, conditioning and packaging of final products, and finally the promotion to prescribers and distribution to wholesalers and pharmacies.
Wockhardt is a pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company employs over 7,000 people globally.
Eurofound (2011), DMH-Negma, Bankruptcy in France, factsheet number 71877, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/71877.